Delivery Order SPE2DB22D1202-SPE2DB25FVLN3
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,647.66 to AmerisourceBergen Drug Corp for the supply of RotaTeq vaccine in 2 milliliter units. This competitively awarded, firm fixed-price delivery order was issued on August 27, 2025, with an ultimate completion date of August 28, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award does not carry a set-aside designation, indicating it was competed among...
- The Defense Logistics Agency awarded a delivery order valued at $2,331.36 to AmerisourceBergen Drug Corp for RotaTeq vaccine (2 mL formulation) on August 25, 2025, with completion scheduled for August 26, 2025. This firm fixed-price, competitively awarded delivery order represents a continuation of the vendor's extensive pharmaceutical supply relationship with DLA's Medical Supply Chain. The award specifies performance at AmerisourceBergen's Conshohocken, Pennsylvania facility, the company's...
- The Defense Logistics Agency awarded a $3,844.54 firm fixed price delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of RotaTeq vaccine (2ML). The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) designated SPE2DX with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. This competitively awarded, non-set-aside contract utilizes the standard delivery order mechanism, with performance...
- The Defense Logistics Agency awarded a delivery order valued at $1,669.81 to AmerisourceBergen Drug Corp for RotaTeq Vaccine 2ml on August 20, 2025, with an ultimate completion date of August 21, 2025. This contract represents a firm fixed-price delivery order with no set-aside designation, competitively awarded through an open procurement process. The vaccine will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, supporting the federal government's...
- The Defense Logistics Agency awarded a delivery order valued at $3,286.08 to AmerisourceBergen Drug Corp for the supply of RotaTeq vaccine in 2ML units. The contract, issued on August 29, 2025, with an ultimate completion date of September 2, 2025, operates under firm fixed pricing with no set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child...
- The Defense Logistics Agency awarded a delivery order valued at $2,671.82 to AmerisourceBergen Drug Corp for RotaTeq Vaccine 2ML on August 19, 2025, with an ultimate completion date of August 20, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation. The contract will be performed at AmerisourceBergen Drug Corp's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $2,746.10 to AmerisourceBergen Drug Corp for the supply of RotaTeq vaccine (2ML formulation) on August 22, 2025, with an ultimate completion date of August 25, 2025. This is a firm fixed price delivery order with no set-aside designation, indicating competitive award status. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a $1,076.56 delivery order to AmerisourceBergen Drug Corp for RotaTeq vaccine (2mL) on July 22, 2025, with an ultimate completion date of July 23, 2025. This competitively awarded, firm fixed-price contract utilized no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order is issued against AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a $2,741.22 firm fixed price delivery order to AmerisourceBergen Drug Corp for RotaTeq vaccine (2 ML) with an ultimate completion date of August 25, 2025. This non-set-aside competitive award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The vaccine will be delivered to AmerisourceBergen's facility in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of RotaTeq vaccine (2ML) on September 10, 2025, with a ceiling value of $13,268.58. This firm fixed-price delivery order, which carries an ultimate completion date of September 11, 2025, represents a child contract under AmerisourceBergen's broader pharmaceutical supply agreement with DLA. The contract was competitively awarded with no set-aside designation and will be performed at the...
- SPE2DB22D1202Indefinite Delivery Contract
- SPE2DB22D1202-SPE2DB25FVLN3Delivery Order
The Defense Logistics Agency awarded a $3,126.67 delivery order to AmerisourceBergen Drug Corp for RotaTeq vaccine (2 mL) on September 16, 2025, with completion targeted for September 17, 2025. This competitive, non-set-aside contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger indefinite delivery contract vehicle with DLA Troop Support Medical. The product will be delivered to the company's distribution facility in Conshohocken, Pennsylvania, supporting federal medical supply chain operations. This delivery order is issued under AmerisourceBergen's comprehensive $999,999,999.00 indefinite delivery contract (SPE2DX) with DLA Troop Support Medical, which extends through December 2026 and serves as a global pharmaceutical support vehicle for military healthcare systems. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has established itself as a critical vendor for federal medical procurement through its extensive portfolio of vaccine and pharmaceutical deliveries to the Defense Health Agency and other government healthcare systems. The RotaTeq vaccine delivery supports DLA's mission to provide essential medical supplies and pharmaceutical products to military personnel and veteran healthcare networks.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.1k | 9/16/25 |